San Jose, CA – According to filings with the U.S. Securities and Exchange Commission, NeuSpera Medical is raising $79,575,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Milton Morris played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NeuSpera Medical
Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neusperas minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.

To learn more about NeuSpera Medical, visit http://neuspera.com/

Contact:
Milton Morris, President and Chief Executive Officer
888-846-8332
milton.morris@neuspera.com
https://www.linkedin.com/in/miltonmorris/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved